The antagonistic pleiotropic impact of DDAH2 expression level on disorders such as multiple sclerosis and type 2 diabetes indicate finding an optimal level is important in regulating the expression of DDAH2 for therapeutic purposes. The gene discussed is DDAH2; the disease is multiple sclerosis.